stockrowCodexis, Inc. (CDXS) vs Coherus Oncology, Inc. (CHRS)
- Codexis, Inc. CDXS 1.07 +4.90%
- Coherus Oncology, Inc. CHRS 0.77 +2.67%
Codexis, Inc. and Coherus Oncology, Inc. are both Biotechnology companies. Codexis, Inc. and Coherus Oncology, Inc. are of similar size ($115.7M and $111.7M). Coherus Oncology, Inc. grew revenue faster over the last twelve months: 61.0% against 35.9%. Codexis, Inc. has the higher net margin (−39.6% vs −259.4%) and the lower return on invested capital (−151.2% vs 0.00%). Across the 19 metrics below, Codexis, Inc. leads on 12 and Coherus Oncology, Inc. on 7.
Valuation
Profitability
| Metric | CDXS | CHRS | Biotechnology median |
|---|---|---|---|
| Gross margin | 87.02% | 68.94% | 68.51% |
| Operating margin | (35.61%) | (311.56%) | 0.00% |
| Net margin | (39.55%) | (259.41%) | 0.00% |
| Free cash flow margin | (15.66%) | (365.22%) | 0.00% |
| Return on equity | (69.36%) | (146.27%) | (51.96%) |
| Return on assets | (23.79%) | (41.90%) | (46.06%) |
| Return on invested capital | (151.17%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack